中科白癜风公益活动依托考昔与塞来昔布治疗急性痛风的疗效与安全性
[摘要] 目的 探讨依托考昔与塞来昔布治疗急性痛风的疗效与安全性。 方法 随机选取该院2013年4月―2014年6月收治的80例急性通风患者，并将其随机分为实验组与对照组，各40例。其中实验组患者采用依托考昔进行口服治疗；对照组患者采用塞来昔布进行口服治疗。对比两组通风患者的各项数据。 结果 两组急性痛风患者进行治疗后发现，实验组患者的其他各项指标均优于对照组患者。两组急性痛风患者治疗后的VAS评分存在明显差异，P中国论文
[关键词] 依托考昔；塞来昔布；急性痛风
[中图分类号] R4 [文献标识码] A [文章编号] （2015）10（a）-
The Efficacy and Safety of Etoricoxib and Celecoxib in the Treatment of Acute Gout
XIA Hong-mei
Department of Pharmacy， Jilin Central Hospital， Jilin， Jilin Province， 132000 China
[Abstract] Objective To investigate the efficacy and safety of etoricoxib and celecoxib in the treatment of acute gout. Methods 80 cases of acute ventilation were selected from April 2013 to June 2014， and were randomly divided into experimental group and control group， 40 cases in each group. In the experimental group were treated with etoricoxib oral treatment； the control group were treated with celecoxib oral treatment. Compare the data of two groups of ventilation patients. Results Two groups of patients with acute gout were treated， the other indicators of the experimental group were better than those of the control group. There were significant differences in VAS score between the two groups after treatment， P0.05，具有对比性。
1.2 方法
实验组患者采用依托考昔进行口服治疗1次/d，120 mg/次，另外加用1.0 g碳酸氢钠片进行口服；对照组患者采用塞来昔布进行口服治疗，200 mg/次，3次/d。两组急性痛风患者均治疗一周[3]。
1.3 观察指标
两组急性痛风患者经过1周治疗后，对其疼痛视觉模拟评分（VAS）进行观察。
1.4 统计方法
两组急性痛风患者进行治疗情况的研究数据，在本次研究结束后，均准确无误的录入到SPSS19.0软件进行统计学处理，计数资料以率（%）表示，对比方法使用χ2检验，计量数据采用（x±s）表示，对比方法为t检验，当P
